Upcoming Webinar :Register now for 'ULIP as an investment during economic recovery' powered by Bajaj Allianz
you are here: HomeNewsWorld

Trump's 200 ventilators ‘donated’ to India cost $2.6 million: Report

The consignment of 200 mobile ventilators will arrive in India by May-end or latest by early June, a report suggests.
May 18, 2020 / 09:35 AM IST
Representative image
Representative image

The estimated cost of each mobile ventilator “donated” by the United States to India is about Rs 10 lakh. The US will airlift 200 such mobile ventilators, According to a report by the Hindustan Times.

A government official told the newspaper that the consignment will arrive by May-end or latest by early June.

“Each of these mobile ventilators is estimated to cost $13,000 (Rs 9.6 lakh at current exchange rates) without accounting for the transportation costs. In all, the ventilators will cost about $2.6 million (or Rs 19.2 crore) plus freight charges,” the official was quoted as saying. Moneycontrol could not independently verify the report.

This cost would be borne by United States Agency for International Development (USAID), government sources told CNBC-TV18.

Underlining the close partnership between the two countries, President Donald Trump, on May 16, announced that the United States would donate ventilators to India.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Follow our LIVE blog for the latest updates of the novel coronavirus pandemic

“I am proud to announce that the United States will donate ventilators to our friends in India. We stand with India and @narendramodi during this pandemic. We’re also cooperating on vaccine development. Together we will beat the invisible enemy!” Trump added in a tweet.

PM Modi responded on Twitter by saying: “Thank you @POTUS @realDonaldTrump. This pandemic is being fought collectively by all of us. In such times, it’s always important for nations to work together and do as much as possible to make our world healthier and free from COVID-19. More power to India – US friendship!”.

In April, at Trump's request, India allowed the export of 50 million hydroxychloroquine tablets to treat COVID-19 patients in the US, the country worst hit by the pandemic.

Click here for Moneycontrol’s full coverage of the novel coronavirus pandemic
Moneycontrol News
first published: May 18, 2020 09:35 am

stay updated

Get Daily News on your Browser
Sections